Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
This dynamic can trouble even the most skilled investors, but luckily for you, we started StockStory to help you navigate these trade-offs and uncover exceptional companies that break the mold. Keeping that in mind, here is one large-cap stock whose competitive advantages creates flywheel effects and two that could be stalling.
Two Large-Cap Stocks to Sell:
Hartford (HIG)
Market Cap: $37.74 billion
Recognizable by its iconic stag logo that dates back to 1810, The Hartford (NYSE: HIG) provides property and casualty insurance, group benefits, and investment products to individuals and businesses across the United States.
Why Are We Cautious About HIG?
- Large revenue base constrains its growth potential, as seen in its unexciting 6.5% annualized increases in net premiums earned over the last five years fell below our expectations for the insurance sector
- Sales are projected to tank by 26.2% over the next 12 months as demand evaporates
- Scale is a double-edged sword because it limits the firm’s capital growth potential compared to its smaller competitors, as reflected in its below-average annual book value per share increases of 5.8% for the last five years
Hartford’s stock price of $137.61 implies a valuation ratio of 1.9x forward P/B. To fully understand why you should be careful with HIG, check out our full research report (it’s free).
Archer-Daniels-Midland (ADM)
Market Cap: $33.6 billion
Transforming crops from the world's most productive agricultural regions into everyday essentials, Archer-Daniels-Midland (NYSE: ADM) processes and transports agricultural commodities like grains and oilseeds while manufacturing ingredients for food, beverages, feed, and industrial applications.
Why Are We Hesitant About ADM?
- Sales tumbled by 7.5% annually over the last three years, showing consumer trends are working against its favor
- Gross margin of 6.5% is an output of its commoditized products
- Earnings per share have dipped by 24.2% annually over the past three years, which is concerning because stock prices follow EPS over the long term
At $69.73 per share, Archer-Daniels-Midland trades at 17x forward P/E. Check out our free in-depth research report to learn more about why ADM doesn’t pass our bar.
One Large-Cap Stock to Watch:
Elevance Health (ELV)
Market Cap: $68.43 billion
Formerly known as Anthem until its 2022 rebranding, Elevance Health (NYSE: ELV) is one of America's largest health insurers, serving approximately 47 million medical members through its network-based managed care plans.
Why Do We Like ELV?
- Products and services resonate with customers, evidenced by its respectable 10.3% annualized sales growth over the last five years
- Enormous revenue base of $197.6 billion gives it leverage over plan holders and advantageous reimbursement terms with healthcare providers
- Stellar returns on capital showcase management’s ability to surface highly profitable business ventures
Elevance Health is trading at $306.50 per share, or 12.2x forward P/E. Is now the right time to buy? See for yourself in our comprehensive research report, it’s free.
Stocks We Like Even More
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
